Bill Ackman Supports Valeant’s Allergan Offer

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan in a cash-and-stock deal valued at $45.7 billion that will give the Canadian company the Botox wrinkle treatment. Pershing Square Capital Management LP, the fund run by Bill Ackman, Allergan’s largest shareholder, supports the offer, Valeant said. Stephanie Ruhle reports on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)
AB InBev to Buy SABMiller for $106 Billion in Record Deal
37:07 - Anheuser-Busch InBev agreed to buy SABMiller for almost 69 billion pounds ($106 billion), raising its bid after several rejections to clinch a record industry deal that will bring one out of every three beers sold worldwide under a single company. Bloomberg's Thomas Buckley has more on "Countdown." (Source: Bloomberg)
  • Should You Be Worried About China's Trade Data?
  • Why the Fed Needs to Raise Interest Rates Now
  • Best of the Web: Is Draghi Losing Trust of Traders?